SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fanny W.S. Ko, Bryan P. Yan, Yat-yin Lam, Jojo H.Y. Chu, Ka-pang Chan, David S.C. Hui, Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress, Respirology, 2016, 21, 1
  2. 2
    Heng-Chen Yao, Xiao-Yun Li, Qian-Feng Han, Lan-Hua Wang, Tao Liu, Yan-Hong Zhou, Mei Zhang, Le-Xin Wang, Elevated serum soluble ST2 levels may predict the fatal outcomes in patients with chronic heart failure, International Journal of Cardiology, 2015, 186, 303

    CrossRef

  3. 3
    Benjamin Dieplinger, Thomas Mueller, Soluble ST2 in heart failure, Clinica Chimica Acta, 2015, 443, 57

    CrossRef

  4. 4
    Thomas Mueller, Allan S. Jaffe, Soluble ST2—Analytical Considerations, The American Journal of Cardiology, 2015, 115, 7, 8B

    CrossRef

  5. 5
    Qian Wang, Chao Wang, Letter to the Editor in response to the Carlomagno et al. article regarding the serum sST2 and IL-33 levels in patients with PAH, International Journal of Cardiology, 2013, 168, 3, 2920

    CrossRef

  6. 6
    Sanne Willems, Paul H.A. Quax, Gert Jan de Borst, Jean-Paul P.M. de Vries, Frans L. Moll, Dominique P.V. de Kleijn, Imo E. Hoefer, Gerard Pasterkamp, Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis, Atherosclerosis, 2013, 231, 1, 48

    CrossRef

  7. 7
    George Karayannis, Filippos Triposkiadis, John Skoularigis, Panagiotis Georgoulias, Javed Butler, Gregory Giamouzis, The Emerging Role of Galectin-3 and ST2 in Heart Failure: Practical Considerations and Pitfalls Using Novel Biomarkers, Current Heart Failure Reports, 2013, 10, 4, 441

    CrossRef